These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 12686463)

  • 1. Synthesis of biologically active canine CCK-58.
    Reeve JR; Keire DA; Coskun T; Green GM; Evans C; Ho FJ; Lee TD; Davis MT; Shively JE; Solomon TE
    Regul Pept; 2003 May; 113(1-3):71-7. PubMed ID: 12686463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural and synthetic CCK-58. Novel reagents for studying cholecystokinin physiology.
    Reeve JR; Eysselein VE; Ho FJ; Chew P; Vigna SR; Liddle RA; Evans C
    Ann N Y Acad Sci; 1994 Mar; 713():11-21. PubMed ID: 7514372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential bile-pancreatic secretory effects of CCK-58 and CCK-8.
    Reeve JR; Wu SV; Keire DA; Faull K; Chew P; Solomon TE; Green GM; Coskun T
    Am J Physiol Gastrointest Liver Physiol; 2004 Mar; 286(3):G395-402. PubMed ID: 14604858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholecystokinin (pancreozymin). 4. Synthesis and properties of a biologically active analogue of the C-terminal heptapeptide with epsilon-hydroxynorleucine sulfate replacing tyrosine sulfate.
    Bodanszky M; Martinez J; Priestley GP; Gardner JD; Mutt V
    J Med Chem; 1978 Oct; 21(10):1030-5. PubMed ID: 722712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence that CCK-58 has structure that influences its biological activity.
    Reeve JR; Eysselein VE; Rosenquist G; Zeeh J; Regner U; Ho FJ; Chew P; Davis MT; Lee TD; Shively JE; Brazer SR; Liddle RA
    Am J Physiol; 1996 May; 270(5 Pt 1):G860-8. PubMed ID: 8967499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological activity of some partially modified retro-inverso analogues of cholecystokinin.
    Rodriguez M; Galas MC; Lignon MF; Mendre C; Laur J; Aumelas A; Martinez J
    J Med Chem; 1989 Oct; 32(10):2331-9. PubMed ID: 2477546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of CCK-tetrapeptide analogues as potent and selective CCK-A receptor agonists.
    Shiosaki K; Lin CW; Kopecka H; Craig R; Wagenaar FL; Bianchi B; Miller T; Witte D; Nadzan AM
    J Med Chem; 1990 Nov; 33(11):2950-2. PubMed ID: 1700123
    [No Abstract]   [Full Text] [Related]  

  • 8. Cholecystokinin receptors: relationships among phosphoinositide breakdown, amylase release and receptor affinity in pancreas.
    Lin CW; Bianchi BR; Grant D; Miller T; Danaher EA; Tufano MD; Kopecka H; Nadzan AM
    J Pharmacol Exp Ther; 1986 Mar; 236(3):729-34. PubMed ID: 2419543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequence variation outside the "active" region of dog and rabbit cholecystokinin-58 results in bioactivity differences.
    Reeve JR; Liddle RA; Shively JE; Lee TD; Keire DA; Chew P; Vigna SR
    Pancreas; 2006 Apr; 32(3):306-13. PubMed ID: 16628087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relative bioactivities of cholecystokinins-8 and -33 on rat pancreatic acini.
    Liddle RA; Elashoff J; Reeve JR
    Peptides; 1986; 7(5):723-7. PubMed ID: 2432584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of ninety-five percent pure cholecystokinin on gastrin-stimulated acid secretion in man and dog.
    Corazziari E; Solomon TE; Grossman MI
    Gastroenterology; 1979 Jul; 77(1):91-5. PubMed ID: 447032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and characterization of a new cholecystokinin receptor probe that can be oxidatively radioiodinated.
    Pearson RK; Hadac EM; Miller LJ
    Gastroenterology; 1986 Jun; 90(6):1985-91. PubMed ID: 3009263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological activity of the C-terminal octapeptide of cholecystokinin, of three of its analogues and of caerulein in the dog.
    Meyer FD; Gyr K; Kayasseh L; Jeker L; Wall M; Trzeciak A; Gillessen D
    Experientia; 1980 Apr; 36(4):434-6. PubMed ID: 7379916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of nonsulfated cholecystokinin-58 in canine intestinal extracts and its biological properties.
    Reeve JR; Liddle RA; McVey DC; Vigna SR; Solomon TE; Keire DA; Rosenquist G; Shively JE; Lee TD; Chew P; Green GM; Coskun T
    Am J Physiol Gastrointest Liver Physiol; 2004 Aug; 287(2):G326-33. PubMed ID: 15064233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of various molecular forms of cholecystokinin from canine mucosa by radioimmunoassay and bioassay.
    Mössner J; Zeeh JM; Eberlein G; Schäffer M; Regner U; Grandt D; Goebell H; Eysselein VE
    Digestion; 1991; 48(4):210-9. PubMed ID: 1724764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects on exocrine and endocrine rat pancreas of long-term administration of CCK-PZ (cholecystokinin-pancreozymin) or synthetic octapeptide - CCK-PZ.
    Arnesjö II; Lundquist I
    Scand J Gastroenterol; 1976; 11(5):529-35. PubMed ID: 785590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of C-terminal fragments of cholecystokinin on exocrine and endocrine secretion from isolated perfused rat pancreas.
    Okabayashi Y; Otsuki M; Ohki A; Sakamoto C; Baba S
    Endocrinology; 1983 Dec; 113(6):2210-15. PubMed ID: 6196184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholecystokinin peptides stimulate pancreatic secretion by multiple signal transduction pathways.
    Yoshida H; Tsunoda Y; Owyang C
    Am J Physiol; 1997 Sep; 273(3 Pt 1):G735-47. PubMed ID: 9316479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Action of cholecystokinin analogues on exocrine and endocrine rat pancreas.
    Otsuki M; Okabayashi Y; Ohki A; Oka T; Fujii M; Nakamura T; Sugiura N; Yanaihara N; Baba S
    Am J Physiol; 1986 Apr; 250(4 Pt 1):G405-11. PubMed ID: 2421584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of a cholecystokinin analogue with partial agonist activity.
    Howard JM; Knight M; Jensen RT; Gardner JD
    Am J Physiol; 1984 Sep; 247(3 Pt 1):G261-4. PubMed ID: 6206732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.